We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
STAQUIS (Pfizer Australia Pty Ltd)
Product name
STAQUIS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
crisaborole
Registration type
NCE/NBE
Indication
STAQUIS (2% w/w ointment) is indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.